ERK5 is targeted to myocyte enhancer factor 2A (MEF2A) through a MAPK docking motif (Q24292700)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q62565833)
(P304) 693-9
(P407) (Q1860)
(P433) Pt 3
(P478) 381
(P577) Sunday, August 1, 2004
(P921) (Q7141)
(Q9026322)
(Q21106227)
(P1433) (Q864221)
(P1476) "ERK5 is targeted to myocyte enhancer factor 2A (MEF2A) through a MAPK docking motif" (language: en)
(P2093) Alex Galanis
Anne Clancy
Andrew D Sharrocks
(P2860) (Q22010041)
(Q24548255)
(Q24532869)
(Q27639263)
(Q28512496)
(Q28137985)
(Q28286729)
(Q28243308)
(Q28583309)
(Q29614227)
(Q29620169)
(Q40757743)
(Q34454906)
(Q33605384)
(Q34023280)
(Q33873104)
(Q33652314)
(Q33632317)
(Q33888516)
(Q34455807)
(Q33770637)
(Q41086909)
(Q41750250)
(Q73072017)
other details
description scientific article

External Links